Bugs as drugs : therapeutic microbes for the prevention and treatment of disease /
Saved in:
Imprint: | Washington, DC : ASM Press, [2018] ©2018 |
---|---|
Description: | 1 online resource ( xiv, 499 pages) |
Language: | English |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11395921 |
MARC
LEADER | 00000nam a2200000 i 4500 | ||
---|---|---|---|
001 | 11395921 | ||
003 | ICU | ||
005 | 20200219103439.5 | ||
006 | m||||||||d|||||||| | ||
007 | cr||n||||||||| | ||
008 | 170927t20182018dcua ob 001 0 eng | ||
010 | |a 2017046421 | ||
020 | |a 9781555819705 |q electronic book | ||
020 | |a 1555819702 |q electronic book | ||
020 | |z 9781555819699 |q print | ||
035 | |a (OCoLC)1004957463 | ||
035 | |a ybp15112354 | ||
040 | |a DLC |b eng |e rda |c DLC |d N$T |d EBLCP |d NhCcYBP | ||
042 | |a pcc | ||
050 | 4 | |a QR46 |b .B84 2018 | |
072 | 7 | |a SCI |x 007000 |2 bisacsh | |
082 | 0 | 0 | |a 572/.472 |2 23 |
245 | 0 | 0 | |a Bugs as drugs : |b therapeutic microbes for the prevention and treatment of disease / |c edited by Robert A. Britton, Baylor College of Medicine, Molecular Virology and Microbiology, Houston, Texas, Patrice D. Cani, Université catholique de Louvain, Louvain Drug Research Institute, WELBIO-Walloon Excellence in Life Sciences, Brussels, Belgium. |
264 | 1 | |a Washington, DC : |b ASM Press, |c [2018] | |
264 | 4 | |c ©2018 | |
300 | |a 1 online resource ( xiv, 499 pages) | ||
336 | |a text |b txt |2 rdacontent |0 http://id.loc.gov/vocabulary/contentTypes/txt | ||
337 | |a computer |b c |2 rdamedia |0 http://id.loc.gov/vocabulary/mediaTypes/c | ||
338 | |a online resource |b cr |2 rdacarrier |0 http://id.loc.gov/vocabulary/carriers/cr | ||
504 | |a Includes bibliographical references and index. | ||
505 | 0 | |a Cover; Half Title; Title Page; Copyright; Contents; Contributors; About the Editors; Preface; A. TRADITIONAL PROBIOTIC APPROACHES; Chapter 1: Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology; BACKGROUND; SIGNALING COMPOUNDS; METABOLITES THAT BENEFIT THE HOST; ANTIMICROBIAL COMPOUNDS; SUMMARY AND CONCLUSIONS; CITATION; REFERENCES; Chapter 2: The Genomic Basis of Lactobacilli asÂ#x92;Health-Promoting Organisms; BENEFICIAL EFFECTS ASSOCIATED WITH LACTOBACILLI; GENOMIC DIVERSITY OF LACTOBACILLI; DISTRIBUTION OF PROBIOTIC-RELATED TRAITS IN LACTOBACILLI | |
505 | 8 | |a INTRASPECIFIC DIVERSITY OF LACTOBACILLUS SPECIES HARBORING PROBIOTIC STRAINSTHE CONTROVERSY IN LACTOBACILLUS TAXONOMY; ACKNOWLEDGMENTS; CITATION; REFERENCES; Chapter 3: Bifidobacteria and Their Health-Promoting Effects; THE BIFIDOBACTERIUM GENUS; BIFIDOBACTERIA AS MEMBERS OF THE HUMAN INTESTINAL MICROBIOTA; BIFIDOBACTERIA AS PROBIOTICS; BIFIDOBACTERIA FOR PREVENTION AND TREATMENT OF DISEASE; CONCLUSIONS; ACKNOWLEDGMENTS; CITATION; REFERENCES; B. NEXT-GENERATION BACTERIOTHERAPY: OPPORTUNITIES IN CHRONIC DISEASES; Chapter 4: Microbial Interactions and Interventions in Colorectal Cancer | |
505 | 8 | |a INTRODUCTIONTHE HOST SIDE: PHYSIOLOGY AND DEVELOPMENT IN COLORECTAL CANCER; COLONIC CRYPT; COLORECTAL CANCER; THE NORMAL COLONIC MICROBIOTA; WHEN THINGS GO AWRY: THE GUT MICROBIOTA ASSOCIATED WITH CRC; THE POTENTIAL FOR TREATING CRC WITH MICROBIAL MODULATION THERAPIES; CONCLUSION: CRC TREATMENT OF THE FUTUREâ#x80;#x94;WHERE DO WE GO FROM HERE?; CITATION; REFERENCES; Chapter 5: Microbial Impact on Host Metabolism: Opportunities for Novel Treatments of Nutritional Disorders?; INTRODUCTION; MICROBIAL CONTRIBUTIONS TO ENERGY HOMEOSTASISâ#x80;#x94;INSIGHTS FROM GERMFREE MICE | |
505 | 8 | |a IMPACT OF THE GUT MICROBIOTA ON MALNUTRITION-ASSOCIATED METABOLIC DISORDERSGUT MICROBES IN CHILDHOOD UNDERNUTRITION; CONCLUSION AND PERSPECTIVES; ACKNOWLEDGMENTS; CITATION; REFERENCES; Chapter 6: Therapeutic Opportunities in the Vaginal Microbiome; SCOPE OF THIS REVIEW; THE CERVICOVAGINAL MICROBIOME AND ITS INFLUENCE ON HEALTH; TARGETS FOR THERAPY: MECHANISMS WHEREBY LACTOBACILLI PROTECT THE HOST; COMMUNITY PROBIOTICS; SUMMARY; ACKNOWLEDGMENTS; CITATION; REFERENCES; Chapter 7: Lung Microbiota and Its Impact on theÂ#x92;Mucosal Immune Phenotype; INTRODUCTION | |
505 | 8 | |a UNIQUE CHALLENGES IN EVALUATING THE LUNG MICROBIOMESOURCES OF MICROBIAL CHALLENGE TO THE LOWER AIRWAYS; UNIQUE SELECTION PRESSURES OF THE LOWER AIRWAY MICROBIOME; THE LUNG MICROBIOME IN DISEASE STATES; THE LUNG-GUT AXIS AND ITS ROLE IN DISEASE; MICROBIOTA EFFECTS ON THE ACTIVATION OF INFLAMMATORY PATHWAYS OF THE LOWER AIRWAY ENVIRONMENT; CONCLUSION; ACKNOWLEDGMENTS; CITATION; REFERENCES; Chapter 8: Microbiota, Liver Diseases, and Alcohol; METABOLIC LIVER DISEASES: FROM DIAGNOSIS TO CURRENT TREATMENTS; NAFLD AND THE GUT MICROBIOTA; ALCOHOL LIVER DISEASE; ADVANCED LIVER DISEASE; CONCLUSION | |
588 | |a Description based on online resource; title from digital title page (viewed on January 30, 2018). | ||
650 | 0 | |a Microorganisms |x Therapeutic use. | |
650 | 0 | |a Bacteria |x Therapeutic use. | |
650 | 0 | |a Medical microbiology. |0 http://id.loc.gov/authorities/subjects/sh85082974 | |
650 | 0 | |a Probiotics. |0 http://id.loc.gov/authorities/subjects/sh2006003499 | |
650 | 7 | |a SCIENCE / Life Sciences / Biochemistry |2 bisacsh | |
650 | 7 | |a Medical microbiology. |2 fast |0 http://id.worldcat.org/fast/fst01014362 | |
650 | 7 | |a Microorganisms |x Therapeutic use. |2 fast |0 http://id.worldcat.org/fast/fst01019969 | |
650 | 7 | |a Probiotics. |2 fast |0 http://id.worldcat.org/fast/fst01740530 | |
700 | 1 | |a Britton, Robert A. |q (Robert Allen), |e editor. |0 http://id.loc.gov/authorities/names/no2017124381 |1 http://viaf.org/viaf/12150686457512540822 | |
700 | 1 | |a Cani, Patrice D., |e editor. |0 http://id.loc.gov/authorities/names/no2017124392 |1 http://viaf.org/viaf/9150686495812541147 | |
776 | 0 | 8 | |i Print version: |t Bugs as drugs |d Washington, DC : ASM Press, [2018] |z 9781555819699 |w (DLC) 2017045971 |
856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1693215 |y EBSCOhost |x 1 |z Licensed for 1 user at a time |
901 | |a YBPebook | ||
903 | |a HeVa | ||
903 | |a HeVa | ||
929 | |a eresource | ||
999 | f | f | |i d7751bc4-fc34-5994-862d-0d532eccfd69 |s 4ea3b20d-c168-524f-ab5c-e982038d9cd4 |
928 | |t Library of Congress classification |a QR46 .B84 2018 |l Online |c UC-FullText |n Licensed for 1 user at a time |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1693215 |z EBSCOhost |g ebooks |e WIST |i 10688195 |